Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217009 · ClinicalTrials.gov registry record · Early Phase 1
Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
A Early Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT00217009: Clinical Trial Early Phase 1 study, sponsored by Mayo Clinic.
NCT00217009 is a Early Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217009, a Early Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Hand and foot skin diseases, such as dermatitis and psoriasis, that do not respond to topical creams can be treated with ultraviolet light therapy. Topical psoralen plus ultraviolet A (PUVA) is commonly used to treat these conditions, but requires additional time for the hands and feet to soak in psoralens before the light treatment. Newer narrowband ultraviolet B (NBUVB) units have become available which allow for light treatment without soaking first. The purpose of this study is to determine if NBUVB is as effective as PUVA for hand and foot skin diseases.
Interventions
- PROCEDURE Narrowband Ultraviolet B (TL-01UVB) Therapy
- PROCEDURE Topical Psoralen plus ultraviolet A (PUVA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-11 |
| Phase | Early Phase 1 |
Why NCT00217009 stopped before completion
NCT00217009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Narrowband Ultraviolet B (TL-01UVB) Therapy is the first listed.
NCT00217009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00217009 about?
NCT00217009 is a clinical study titled "Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.". Hand and foot skin diseases, such as dermatitis and psoriasis, that do not respond to topical creams can be treated with ultraviolet light therapy. Topical psoralen plus ultraviolet A (PUVA) is commonly used to treat these conditions, but requires additional time for the hands and feet to soak in ps...
What is the current status of trial NCT00217009?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2005-03. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00217009?
The interventions under investigation include: Narrowband Ultraviolet B (TL-01UVB) Therapy (PROCEDURE), Topical Psoralen plus ultraviolet A (PUVA) (PROCEDURE).
Who is sponsoring clinical trial NCT00217009?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00217009's enrollment target sits among peer trials
3 1948th of 2000 higher than 28 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia